These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7511313)

  • 1. [Circulatory hyperkinesis of cirrhosis: etiopathogenesis, clinical and therapeutic implications].
    Denie C; Henrion J
    Acta Gastroenterol Belg; 1993; 56(5-6):338-46. PubMed ID: 7511313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
    Michielsen PP; Pelckmans PA
    Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.
    Martin PY; Ginès P; Schrier RW
    N Engl J Med; 1998 Aug; 339(8):533-41. PubMed ID: 9709047
    [No Abstract]   [Full Text] [Related]  

  • 4. Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis.
    Arroyo V; Ginés P
    Gastroenterology; 1992 Mar; 102(3):1077. PubMed ID: 1537501
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.
    Bolognesi M; Di Pascoli M; Verardo A; Gatta A
    World J Gastroenterol; 2014 Mar; 20(10):2555-63. PubMed ID: 24627591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
    Møller S; Bendtsen F
    Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic alterations in liver cirrhosis.
    La Villa G; Gentilini P
    Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulatory dysfunction syndrome associated with liver cirrhosis].
    Hartleb M
    Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
    Kim MY; Baik SK
    Korean J Gastroenterol; 2009 Sep; 54(3):143-8. PubMed ID: 19844149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of sodium retention and ascites formation in cirrhosis.
    Arroyo V; Ginès P
    J Hepatol; 1993; 17 Suppl 2():S24-8. PubMed ID: 8491967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide and portal hypertension.
    González-Abraldes J; García-Pagán JC; Bosch J
    Metab Brain Dis; 2002 Dec; 17(4):311-24. PubMed ID: 12602508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites.
    Cárdenas A; Arroyo V
    Best Pract Res Clin Endocrinol Metab; 2003 Dec; 17(4):607-22. PubMed ID: 14687592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiopathology of ascites in portal hypertension.
    Michielsen PP
    Acta Gastroenterol Belg; 1996; 59(3):191-7. PubMed ID: 9015930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
    Afzelius P; Bazeghi N; Bie P; Bendtsen F; Vestbo J; Møller S
    Liver Int; 2011 Oct; 31(9):1381-7. PubMed ID: 21745317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.